Title of article
Editorial: Is Assessing the Presence of NASH by Liver Histology or Surrogate Markers Always Advisable?
Author/Authors
Tarantino, Giovanni Federico II University Medical - School of Naples - Department of Clinical and Experimental Medicine, Italy
From page
1
To page
4
Abstract
To gather objective evidence for the effectiveness of their interventions, should responsible clinicians rely on the necessity to better characterize patients with nonalcoholic fatty liver disease as being affected by the benign or progressive form (simple fatty liver or nonalcoholic steatohepatitis) and by which means? Disease markers, imaging tools, histology?
Keywords
Liver , Histology , Biological Markers
Journal title
Hepatitis Monthly
Journal title
Hepatitis Monthly
Record number
2557859
Link To Document